In addition, specific treatment strategies for the phenotype of sarcopenic obesity should be adopted, to prevent detrimental changes in body composition due to the altered GH/ IGF- 1 status. This evidence concerns the gene GH1 and obesity due to melanocortin 4 receptor deficiency.